Vibration Training in Chronic Obstructive Pulmonary Disease (COPD)-Patients During a Three-week Rehabilitation

Not Applicable

Completed

• Conditions: Chronic Obstructive Pulmonary Disease

• Registration Number: NCT01380652
• Lead Sponsor: Schön Klinik Berchtesgadener Land

Brief Summary

The aim of this study is to investigate the change of physical activity in COPD-patients performing a whole body vibration training additional to a standard three-week rehabilitation program in comparison to patients performing merely a standard rehabilitation program.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-09
• Primary Completion: 2011-02
• Study First Submitted: 2011-04-01
• Study Completion: 2011-05
• Study First Submitted QC: 2011-06-23
• Study First Posted: 2011-06-27
• Status Verified: 2015-03
• Last Update Submitted: 2015-03-05
• Last Update Posted: 2015-03-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

• Chronic obstructive pulmonary disease III/IV

Exclusion Criteria

• Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics))
• Severe disease other than COPD, that could influence the results of the study
• Abuse of alcohol or drugs
• Simultaneously participation in another study
• Tachypnea (>30/min)
• Severe exacerbation during rehabilitation
• Cardiac insufficiency (NYHA IV)
• Myocardial infarction during the last 6 weeks
• Mental-health problem
• Pregnancy
• Known HIV-infection
• Slipped disk
• Acute discopathy
• Acute thrombosis
• Implants in trained regions of the body (lower extremities)
• Acute inflammation of the locomotor system, active arthrosis or rheumatoid arthritis
• Acute tendinopathy in trained regions of the body
• Acute hernia
• Fresh fractures, wounds or scars in trained regions of the body
• Gallstones or stones in the urinary tract collection system

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Activity	day 2 and 17	change in activity from baseline to day 17

Secondary Outcome Measures

Name	Time	Method
BODE-Score	day 1 and 19	Changes in Bode-Score from baseline to day 19
Diffusion Capacity	day 1
lung function	day 1

Trial Locations

Locations (1)

Klinikum Berchtesgadener Land, Schön Kliniken; 🇩🇪 Schönau am Königssee, Germany